Analyzing the Estrogen Receptor Status of Liver Metastases with [18F]-FES-PET in Patients with Breast Cancer.
Jorianne BoersNaila LoudiniRobbert J de HaasAntoon T M WillemsenBert Van der VegtElisabeth G E de VriesGeke A P HospersCarolina P SchröderAndor W J M GlaudemansErik F J de VriesPublished in: Diagnostics (Basel, Switzerland) (2021)
In the majority of liver metastases, ER status can be determined with [18F]-FES-PET if background correction and separate thresholds are applied.